Apraclonidine hydrochloride

盐酸阿拉可乐定

Report date: 2026/05/12 20:00:17
NME

Base Information

Drug NameApraclonidine hydrochloride
Drug Alias Nameapraclonidina安普尼定阿可乐宁apraclonidinumAplonidine hydrochloride +[18] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors agonists
TargetsAdrenergic receptors
Therapy Area/IndicationsOcular HypertensionEye DiseasesMyasthenia Gravis
Global Approved IndicationsOcular Hypertension
Approved Indications in ChinaOcular Hypertension
Original Approved Country/TerritoryUnited States
Original Approved Date1987/12/31
Country/TerritoryUnited StatesUnited KingdomLebanon +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesClinigen LtdHarrow Eye LLCAlcon Laboratories (U.K.) Ltd +[5] 
Inactive CompaniesAlconAmerican University Of Beirut Medical Center
Active IndicationsOcular Hypertension
Inactive IndicationsEye DiseasesMyasthenia Gravis

Other Information

ATC CodeS01EA03
Related LinksWikipediaDrugBankKEGG